Salpingectomy at the Time of Elective Laparoscopic Cholecystectomy (SaLCHE)
NCT ID: NCT03171467
Last Updated: 2018-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2016-08-01
2018-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Salpingectomy on Ovarian Reserve
NCT02284711
Feasibility of Opportunistic Salpingectomy at the Time of Vaginal Hysterectomy for Benign Pathology
NCT03187327
Feasibility of Opportunistic Salpingectomy During Non-Gynecologic Surgery
NCT04176484
Does Vnotes Salpingectomy Reduce Ovarian Reserve?
NCT07177144
Impact of Opportunistic Salpingectomy on Ovarian Reserve in Patients Undergoing Laparoscopic Hysterectomy
NCT01893086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study explores the acceptability and feasibility of incidental (opportunistic, risk-reducing, prophylactic) salpingectomy at the time of a common nongynecologic procedure in women, i.e. elective laparoscopic cholecystectomy (LCHE). The study addresses whether women ≥45 years would accept opportunistic salpingectomy and the technical feasibility (time, port placement, complications) in women who consented to salpingectomy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Salpingectomy
Opportunistic salpingectomy at the time of laparoscopic cholecystectomy
Salpingectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Salpingectomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>45 years
* Consent
Exclusion Criteria
* Desire to preserve fertility
* Cholecystectomy for malignant disease
* Extensive previous abdominal surgery
45 Years
75 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Krankenhaus der Barmherzigen Brüder Graz
UNKNOWN
Krankenhaus der Elisabethinen Graz
UNKNOWN
Landeskrankenhaus Feldbach
OTHER
LKH Hartberg
UNKNOWN
Krankenhaus der Barmherzigen Brüder St. Veit/Glan
UNKNOWN
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karl F Tamussino, MD
Role: STUDY_CHAIR
Medical University of Graz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Landeskrankenhaus Feldbach
Feldbach, , Austria
Krankenhaus der Barmherzigen Brüder Graz
Graz, , Austria
Krankenhaus der Elisabethinen Graz
Graz, , Austria
Medical University of Graz
Graz, , Austria
Landeskrankenhaus Hartberg
Hartberg, , Austria
Krankenhaus der Barmherzigen Brüder St. Veit/Glan
Saint Veit/Glan, , Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Long Roche KC, Abu-Rustum NR, Nourmoussavi M, Zivanovic O. Risk-reducing salpingectomy: Let us be opportunistic. Cancer. 2017 May 15;123(10):1714-1720. doi: 10.1002/cncr.30528. Epub 2017 Mar 23.
Committee opinion no. 620: Salpingectomy for ovarian cancer prevention. Obstet Gynecol. 2015 Jan;125(1):279-281. doi: 10.1097/01.AOG.0000459871.88564.09.
Falconer H, Yin L, Gronberg H, Altman D. Ovarian cancer risk after salpingectomy: a nationwide population-based study. J Natl Cancer Inst. 2015 Jan 27;107(2):dju410. doi: 10.1093/jnci/dju410. Print 2015 Feb.
Kurman RJ, Shih IeM. The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded. Am J Pathol. 2016 Apr;186(4):733-47. doi: 10.1016/j.ajpath.2015.11.011.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SaLCHE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.